Anaconda BioMed is a pre-clinical stage medical device company focused on the development of next generation neuro-thrombectomy systems for the treatment of Acute Ischemic Stroke. The Company's product, ANCD Brain®, is a novel device intended to be used to restore blood flow in patients experiencing an acute ischemic stroke due to a large vessel neurovascular occlusion. The Device is indicated for thrombus removal by aspiration in intracranial arteries but it remains compatible and can be used in combination with other interventional devices.

HQBarcelona, ES
Size (employees)22 (est)
Anaconda Biomed was founded in 2015 and is headquartered in Barcelona, ES
Report incorrect company information

Viewing summary data as a guest

Sign up for free to see all data

Anaconda Biomed Office Locations

Anaconda Biomed has an office in Barcelona
Show all (1)
Report incorrect company information

Anaconda Biomed Financials and Metrics

Summary Metrics

Founding Date


Anaconda Biomed total Funding

$16.8 m

Anaconda Biomed latest funding size

$16.83 m

Time since last funding

a year ago

Anaconda Biomed investors

Anaconda Biomed's latest funding round in May 2017 was reported to be $16.8 m. In total, Anaconda Biomed has raised $16.8 m
Show all financial metrics
Report incorrect company information

Anaconda Biomed Online and Social Media Presence

Embed Graph
Report incorrect company information

Anaconda Biomed Company Life and Culture

Report incorrect company information